Mercer Global Advisors
ANRO icon

Mercer Global Advisors’s Alto Neuroscience ANRO Stock Holding History

Mercer Global Advisors’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$369 Buy
+14
New +$324 ﹤0.01% 5859

Other funds holding ANRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Mercer Global Advisors's ANRO Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Alto Neuroscience (ANRO) in Q2 2026: 14 shares worth $369. The stake represents ﹤0.01% of the portfolio and ranks #5859 among its holdings.

66 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Mercer Global Advisors held 14 shares of Alto Neuroscience worth $369 as of Q2 2026.
  • Alto Neuroscience was a new Mercer Global Advisors position in Q2 2026.
  • Alto Neuroscience made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5859 holding.
  • 66 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.